Bad Haring

Researchers are investigating the effect of extracorporeal shock wave therapy (ESWT) on people with acute traumatic spinal cord injuries, both complete and incomplete, within 48 hours of the trauma. The study focuses on the secondary injury phase, which occurs minutes to weeks after the initial mechanical injury, causing further neurological damage through processes like inflammation, neurotoxicity, and scarring. This phase offers a potential window for therapeutic intervention to reduce neurological deterioration after spinal cord injury. The study compares the use of a high-energy shockwave device called orthogold 100® to a placebo using a dummy head that refrains shock waves. ESWT is applied early after injury to see if it can improve motor and sensory function over six months. This device produces strong acoustic waves believed to enhance metabolic activity and support nerve regeneration, based on previous animal studies showing improved motor function and reduced neuronal loss. Participants will be monitored for changes in their total motor scores from baseline to six months after injury. During the study, assessments will evaluate motor and sensory function, with safety and neurological progress tracked closely. The trial is randomized, double-blind, and placebo-controlled, ensuring reliable comparison between the ESWT treatment and the sham device. Participants’ involvement spans from hospital admission through six months of follow-up to assess the potential benefits and safety of ESWT for spinal cord injury recovery.